Similar to Kdm4d inhibitors, bromodomain and extraterminal motif (BET) inhibitors, when combined with BRAF/MEK inhibitors, can also efficiently kill melanoma cell lines mutated for BRAF [54,80]. Here, MAP2K7 is linked to melanoma.